Halda appoints new chief executive

1 October 2024

Halda Therapeutics, a US biotech company advancing cancer treatments, has announced the appointment of Christian Schade as president and chief executive.

Bringing over 20 years of industry experience, Mr Schade joins the company as it prepares to enter a critical phase in the clinical development of its novel cancer therapy platform, RIPTAC (Regulated Induced Proximity Targeting Chimeras).

He has previously served in leadership roles at several biotech companies, including as CEO of Aprea Therapeutics (Nasdaq: APRE), where he led the firm through its IPO.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK